SCHEDULE 13G/A
Statement of Beneficial Ownership
GH Research PLC Filed Acc 0000921895-26-003180
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BVF PARTNERS L P/IL | 8,650,158 | 12.6% |
| BVF INC/IL | 8,650,158 | 12.6% |
| LAMPERT MARK N | 8,650,158 | 12.6% |
| BVF GP HOLDINGS LLC | 8,039,480 | 11.7% |
| BIOTECHNOLOGY VALUE FUND L P | 4,507,690 | 6.6% |
| BVF I GP LLC | 4,507,690 | 6.6% |
| BIOTECHNOLOGY VALUE FUND II LP | 3,531,790 | 5.1% |
| BVF II GP LLC | 3,531,790 | 5.1% |
| Biotechnology Value Trading Fund OS LP | 610,678 | 0.9% |
| BVF Partners OS Ltd. | 610,678 | 0.9% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…